Aurora-A Phosphorylates, Activates, and Relocalizes the Small GTPase RalA
Open accessThe DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Abstract
The small GTPase Ras, which transmits extracellular signals to the cell, and the kinase Aurora-A, which promotes proper mitosis, can both be inappropriately activated in human tumors. Here, we show that Aurora-A in conjunction with oncogenic Ras enhances transformed cell growth. Furthermore, such transformation and in some cases also tumorigenesis depend upon S194 of RalA, a known Aurora-A phosphorylation site. Aurora-A promotes not only RalA activation but also translocation from the plasma membrane and activation of the effector protein RalBP1. Taken together, these data suggest that Aurora-A may converge upon oncogenic Ras signaling through RalA.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, AURKA, in turn, promotes resistance to therapeutic targeting of EGFR and RAS pathway components by activating RAS downstream effectors such as RalA, ERK1/2, and AKT [132–134].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [133]
Citations
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345
Self-citationRAS oncogenes: the first 30 years
Malumbres, M., & Barbacid, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1097 · Cited by 1,902 · cited 1×
“One-third of human cancers harbor point mutations in Ras that render the protein in a constitutively active GTP-bound state, promoting a host of cancer cell phenotypes (40).”
BackgroundGenetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216
Rodriguez-Viciana, P., Warne, P. H., Khwaja, A., Marte, B. M., Pappin, D., Das, P., Waterfield, M. D., Ridley, A., & Downward, J. (1997) · Cell · doi:10.1016/s0092-8674(00)80226-3 · Cited by 1,061
Aurora-A — A guardian of poles
Marumoto, T., Zhang, D., & Saya, H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1526 · Cited by 697
Aurora-kinase inhibitors as anticancer agents
Keen, N., & Taylor, S. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1502 · Cited by 675
Research works printed but not linked: 4
- Bos J. L., 1989, Cancer Res, 49, 4682
- Li D., 2003, Clin. Cancer Res, 9, 991
- Park S. H., 1995, Oncogene, 11, 2349
- Wolthuis R. M., 1996, Oncogene, 13, 353
Cited by
Drugging the undruggable RAS: Mission Possible?
Cox, A. D., Fesik, S. W., Kimmelman, A. C., Luo, J., & Der, C. J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4389 · Cited by 1,997
Self-citationRas superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?
Vigil, D., Cherfils, J., Rossman, K. L., & Der, C. J. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2960 · Cited by 819
Self-citationRas history: The saga continues
Cox, A. D., & Der, C. J. (2010) · Small GTPases · doi:10.4161/sgtp.1.1.12178 · Cited by 706
Self-citationTargeting protein prenylation for cancer therapy
Berndt, N., Hamilton, A. D., & Sebti, S. M. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3151 · Cited by 614
Rapid non-uniform adaptation to conformation-specific KRAS(G12C) inhibition
Xue, J. Y., Zhao, Y., Aronowitz, J., Mai, T. T., Vides, A., Qeriqi, B., Kim, D., Li, C., de Stanchina, E., Mazutis, L., et al. (2020) · Nature · doi:10.1038/s41586-019-1884-x · Cited by 543
Aurora A kinase (AURKA) in normal and pathological cell division
Nikonova, A. S., Astsaturov, I., Serebriiskii, I. G., Dunbrack, R. L., & Golemis, E. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1073-7 · Cited by 448
Inhibition of Ras for Cancer Treatment: The Search Continues
Baines, A. T., Xu, D., & Der, C. J. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.121 · Cited by 382
Self-citationRALA and RALBP1 regulate mitochondrial fission at mitosis
Kashatus, D. F., Lim, K.-H., Brady, D. C., Pershing, N. L. K., Cox, A. D., & Counter, C. M. (2011) · Nature Cell Biology · doi:10.1038/ncb2310 · Cited by 380
Self-citationVallejo, A., Perurena, N., Guruceaga, E., Mazur, P. K., Martinez-Canarias, S., Zandueta, C., Valencia, K., Arricibita, A., Gwinn, D., Sayles, L. C., et al. (2017) · Nature Communications · doi:10.1038/ncomms14294 · Cited by 181
Plotnikova, O. V., Nikonova, A. S., Loskutov, Y. V., Kozyulina, P. Y., Pugacheva, E. N., & Golemis, E. A. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-12-1056 · Cited by 154
Rac1 signalling towards GLUT4/glucose uptake in skeletal muscle
Chiu, T. T., Jensen, T. E., Sylow, L., Richter, E. A., & Klip, A. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.05.022 · Cited by 155
Aurora kinase inhibitors as anticancer molecules
Katayama, H. G., & Sen, S. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.09.004 · Cited by 141
LST1 promotes the assembly of a molecular machinery responsible for tunneling nanotube formation
Schiller, C., Diakopoulos, K. N., Rohwedder, I., Kremmer, E., von Toerne, C., Ueffing, M., Weidle, U. H., Ohno, H., & Weiss, E. H. (2012) · Journal of Cell Science · doi:10.1242/jcs.114033 · Cited by 134
The RalGEF-Ral Effector Signaling Network: The Road Less Traveled for Anti-Ras Drug Discovery
Neel, N. F., Martin, T. D., Stratford, J. K., Zand, T. P., Reiner, D. J., & Der, C. J. (2011) · Genes & Cancer · doi:10.1177/1947601911407329 · Cited by 130
Self-citationAurora kinase A in gastrointestinal cancers: time to target
Katsha, A. M., Belkhiri, A., Goff, L. W., & El-Rifai, W. M. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0375-4 · Cited by 126
RAL GTPases: Biology and Potential as Therapeutic Targets in Cancer
Yan, C., & Theodorescu, D. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014415 · Cited by 119
“Phosphorylation of RALA by Aurora A relocates RALA from plasma membrane to endomembranes where RALA interacts with RALBP1 and is required for RALA mediated anchorage-independent growth and tumorigenicity in human cancer cells (Lim et al., 2010).”
BackgroundInfluentialRal small GTPase signaling and oncogenesis: More than just 15minutes of fame
Gentry, L. R., Martin, T. D., Reiner, D. J., & Der, C. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.09.004 · Cited by 111
Self-citationMultiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
Palmieri, G., Ombra, M. N., Colombino, M., Casula, M., Sini, M. C., Manca, A., Paliogiannis, P., Ascierto, P. A., & Cossu, A. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00183 · Cited by 120
Aurora kinase A localises to mitochondria to control organelle dynamics and energy production
Bertolin, G., Bulteau, A., Alves‐Guerra, M., Burel, A., Lavault, M.-T., Gavard, O., Bras, S. L., Gagné, J., Poirier, G. G., Borgne, R. L., et al. (2018) · eLife · doi:10.7554/elife.38111 · Cited by 100
Mukerji, J., Olivieri, K. C., Misra, V., Agopian, K. A., & Gabuzda, D. (2012) · Retrovirology · doi:10.1186/1742-4690-9-33 · Cited by 92
Adhikari, H., & Counter, C. M. (2018) · Nature Communications · doi:10.1038/s41467-018-05692-6 · Cited by 91
Self-citationInsights into the non-mitotic functions of Aurora kinase A: more than just cell division
Bertolin, G., & Tramier, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03310-2 · Cited by 88
Peschard, P., McCarthy, A., Leblanc-Dominguez, V., Yeo, M., Guichard, S., Stamp, G., & Marshall, C. J. (2012) · Current Biology · doi:10.1016/j.cub.2012.09.013 · Cited by 82
Ral GTPases: crucial mediators of exocytosis and tumourigenesis
Shirakawa, R., & Horiuchi, H. (2015) · Journal of Biochemistry · doi:10.1093/jb/mvv029 · Cited by 76
Aurora kinases in head and neck cancer
Mehra, R., Serebriiskii, I. G., Burtness, B. A., Astsaturov, I. A., & Golemis, E. A. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70128-1 · Cited by 80
Neel, N. F., Rossman, K. L., Martin, T. D., Hayes, T. K., Yeh, J. J., & Der, C. J. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06291-11 · Cited by 71
Self-citationAurora kinase A inhibitors: promising agents in antitumoral therapy
Malumbres, M., & de Castro, I. P. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.956085 · Cited by 71
RalBP1 is necessary for metastasis of human cancer cell lines
Wu, Z., Owens, C., Chandra, N., Popovic, K., Conaway, M., & Theodorescu, D. (2010) · Neoplasia · doi:10.1593/neo.101080 · Cited by 70
Intrinsically disordered proteins and membranes: a marriage of convenience for cell signalling?
Cornish, J., Chamberlain, S. G., Owen, D., & Mott, H. R. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200467 · Cited by 69
Phosphorylation of RalB Is Important for Bladder Cancer Cell Growth and Metastasis
Wang, H., Owens, C., Chandra, N., Conaway, M. R., Brautigan, D. L., & Theodorescu, D. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0952 · Cited by 67
Guo, L., Wang, Z., Du, Y., Mao, J., Zhang, J., Yu, Z., Guo, J., Zhao, J., Zhou, H., Wang, H., et al. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01274-z · Cited by 67
Vigil, D., Martin, T. D., Williams, F., Yeh, J. J., Campbell, S. L., & Der, C. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.116756 · Cited by 65
Self-citationRal GTPases in tumorigenesis: Emerging from the shadows
Kashatus, D. F. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.06.020 · Cited by 60
Self-citationAurora kinase targeting in lung cancer reduces KRAS-induced transformation
dos Santos, E. O., Carneiro-Lobo, T. C., Aoki, M. N., Levantini, E., & Bassères, D. S. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0494-6 · Cited by 64
“Lim KH, OHayer K, Adam SJ, Kendall SD, Campbell PM, Der CJ, et al. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.”
BackgroundInfluentialRal signaling pathway in health and cancer
Moghadam, A. R., Patrad, E., Tafsiri, E., Peng, W., Fangman, B., Pluard, T. J., Accurso, A., Salacz, M., Shah, K., Ricke, B., et al. (2017) · Cancer Medicine · doi:10.1002/cam4.1105 · Cited by 58
Coupling mitochondrial and cell division
Yamano, K., & Youle, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2334 · Cited by 61
Genetic alterations in RAS ‐regulated pathway in acral lentiginous melanoma
Puig‐Butillé, J. A., Bádenas, C., Ogbah, Z., Carrera, C., Aguilera, P., Malvehy, J., & Puig, S. (2012) · Experimental Dermatology · doi:10.1111/exd.12080 · Cited by 54
Fixing the GAP: The role of RhoGAPs in cancer
Kreider-Letterman, G., Carr, N. M., & García‐Mata, R. (2022) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2022.151209 · Cited by 58
TD-60 links RalA GTPase function to the CPC in mitosis
Papini, D., Langemeyer, L., Abad, M. A., Kerr, A. R. W., Samejima, I., Eyers, P. A., Jeyaprakash, A. A., Higgins, J. M. G., Barr, F. A., & Earnshaw, W. C. (2015) · Nature Communications · doi:10.1038/ncomms8678 · Cited by 54
Mobley, A. K., Zhang, S., Bondaruk, J. E., Wang, Y., Majewski, T., Caraway, N. P., Huang, L., Shoshan, E., Velázquez-Torres, G., Nitti, G., et al. (2017) · Scientific Reports · doi:10.1038/srep40714 · Cited by 51
RalA signaling pathway as a therapeutic target in hepatocellular carcinoma (HCC)
Ezzeldin, M., Borrego-Diaz, E., Taha, M., Esfandyari, T., Wise, A. L., Peng, W., Rouyanian, A., Asvadi Kermani, A., Soleimani, M., Patrad, E., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.03.020 · Cited by 46
Ral activation promotes melanomagenesis
Zipfel, P. A., Brady, D. C., Kashatus, D. F., Ancrile, B. D., Tyler, D. S., & Counter, C. M. (2010) · Oncogene · doi:10.1038/onc.2010.224 · Cited by 47
“Alternatively, RalA was recently shown to be phosphorylated moreover, this phosphorylation was required for the oncogenic activity of the protein (Wu et al., 2005; Sablina et al., 2007; Lim et al., 2010), raising the possibility of targeting RalA by inhibiting more druggable kinases.”
Self-citationThe RalB-RLIP76 Complex Reveals a Novel Mode of Ral-Effector Interaction
Fenwick, R. B., Campbell, L. J., Rajasekar, K., Prasannan, S., Nietlispach, D., Camonis, J., Owen, D., & Mott, H. R. (2010) · Structure · doi:10.1016/j.str.2010.05.013 · Cited by 46
Gentry, L. R., Nishimura, A., Cox, A. D., Martin, T. D., Tsygankov, D., Nishida, M., Elston, T. C., & Der, C. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.656710 · Cited by 47
Self-citationRalGPS2 is involved in tunneling nanotubes formation in 5637 bladder cancer cells
D’Aloia, A., Berruti, G., Costa, B., Schiller, C., Ambrosini, R., Pastori, V., Martegani, E., & Ceriani, M. (2018) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.11.036 · Cited by 41
The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer
Guin, S., & Theodorescu, D. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.129 · Cited by 46
Zheng, X., Guo, J. P., Yang, H., Kanai, M., He, L., Li, Y., Koomen, J. M., Minton, S., Gao, M., Ren, X. B., et al. (2013) · Oncogene · doi:10.1038/onc.2013.444 · Cited by 39
RetractedPhosphorylation and activation of androgen receptor by Aurora-A.
Shu, S.-K., Liu, Q., Coppola, D., & Cheng, J. Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.121129 · Cited by 38
RetractedMartin, T. D., Mitin, N., Cox, A. D., Yeh, J. J., & Der, C. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.344986 · Cited by 38
Self-citationAlan, J. K., Berzat, A. C., Dewar, B. J., Graves, L. M., & Cox, A. D. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01646-09 · Cited by 36
Self-citationThuya, W. L., Kong, L. R., Syn, N. L. X., Ding, L., Cheow, E. S. H., Wong, R. T. X., Wang, T., Goh, R. M., Song, H., Jayasinghe, M. K., et al. (2023) · Theranostics · doi:10.7150/thno.72297 · Cited by 37
Differential involvement of RalA and RalB in colorectal cancer
Martin, T. D., & Der, C. J. (2012) · Small GTPases · doi:10.4161/sgtp.19571 · Cited by 36
Self-citationHiatt, S. M., Neu, M. B., Ramaker, R. C., Hardigan, A. A., Prokop, J. W., Hančárová, M., Prchalová, D., Havlovičová, M., Prchal, J., Stránecký, V., et al. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007671 · Cited by 37
Mitotic protein kinase-driven crosstalk of machineries for mitosis and metastasis
Kim, C.-H., Kim, D., Kim, D., Min, G.-H., Park, J., Kim, Y.-B., Sung, C. K., & Yim, H. (2022) · Experimental & Molecular Medicine · doi:10.1038/s12276-022-00750-y · Cited by 35
RAS Function in cancer cells: translating membrane biology and biochemistry into new therapeutics
Kattan, W. E., & Hancock, J. F. (2020) · Biochemical Journal · doi:10.1042/bcj20190839 · Cited by 36
Treekitkarnmongkol, W., Katayama, H. G., Kai, K., Sasai, K., Jones, J. C., Wang, J., Shen, L., Şahin, A. A., Gagea, M., Ueno, N. T., et al. (2016) · Carcinogenesis · doi:10.1093/carcin/bgw097 · Cited by 37
The RAL Enigma: Distinct Roles of RALA and RALB in Cancer
Richardson, D. S., Spehar, J. M., Han, D. T., Chakravarthy, P. A., & Sizemore, S. T. (2022) · Cells · doi:10.3390/cells11101645 · Cited by 31
“RALA has two Aurora kinase A (AURKA) phosphorylation sites, serine residues S183 and S194, not shared with RALB [77].”
BackgroundThe RAL signaling network: Cancer and beyond
Apken, L. H., & Oeckinghaus, A. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.10.005 · Cited by 32
Grant, B., Enomoto, M., Ikura, M., & Marshall, C. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082751 · Cited by 29
Neyraud, V., Aushev, V. N., Hatzoglou, A., Meunier, B., Cascone, I., & Camonis, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357764 · Cited by 28
The significant others of aurora kinase a in cancer: combination is the key
Nikhil, K., & Shah, K. (2024) · Biomarker Research · doi:10.1186/s40364-024-00651-4 · Cited by 30
Pawar, A., Meier, J. A., Dasgupta, A., Diwanji, N., Deshpande, N., Saxena, K., Buwa, N., Inchanalkar, S., Schwartz, M. A., & Balasubramanian, N. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.05.023 · Cited by 29
Aurora kinase A interacts with H-Ras and potentiates Ras-MAPK signaling
Umstead, M., Xiong, J., Qi, Q., Du, Y., & Fu, H. (2017) · Oncotarget · doi:10.18632/oncotarget.15049 · Cited by 29
Driver mutations: A roadmap for getting close and personal in pancreatic cancer
Korc, M. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.13128 · Cited by 31
Ral GTPase Down-regulation Stabilizes and Reactivates p53 to Inhibit Malignant Transformation
Tecleab, A., Zhang, X., & Sebti, S. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.565796 · Cited by 32
Epis, M. R., Giles, K. M., Beveridge, D. J., Richardson, K. L., Candy, P. A., Stuart, L. M., Bentel, J. M., Cohen, R. J., & Leedman, P. J. (2017) · Oncotarget · doi:10.18632/oncotarget.18664 · Cited by 30
RAS‐targeted cancer therapy: Advances in drugging specific mutations
Liu, C., Ye, D., Yang, H., Chen, X., Su, Z., Li, X., Ding, M., & Liu, Y. (2023) · MedComm · doi:10.1002/mco2.285 · Cited by 30
Inhibition of Ral GTPases Using a Stapled Peptide Approach
Thomas, J. C., Cooper, J. M., Clayton, N. S., Wang, C., White, M. A., Abell, C., Owen, D., & Mott, H. R. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720243 · Cited by 26
PHLPPing the balance: restoration of protein kinase C in cancer
Tovell, H., & Newton, A. C. (2021) · Biochemical Journal · doi:10.1042/bcj20190765 · Cited by 26
Response to MLN8237 in Pancreatic Cancer Is Not Dependent on RalA Phosphorylation
Neel, N. F., Stratford, J. K., Shinde, V., Ecsedy, J., Martin, T. D., Der, C. J., & Yeh, J. J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1232 · Cited by 21
Self-citationStructure and function of RLIP76 (RalBP1): an intersection point between Ras and Rho signalling
Mott, H. R., & Owen, D. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130231 · Cited by 23
Mitotic Failures in Cancer: Aurora B Kinase and its Potential Role in the Development of Aneuploidy
Hegyi, K., & Méhes, G. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-012-9534-8 · Cited by 21
Negative Regulation of the RalGAP Complex by 14-3-3
Leto, D. E., Uhm, M., Williams, A., Chen, X., & Saltiel, A. R. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426106 · Cited by 19
Inchanalkar, S., Deshpande, N. U., Kasherwal, V., Jayakannan, M., & Balasubramanian, N. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00163 · Cited by 17
RalA is overactivated in medulloblastoma
Ginn, K. F., Fangman, B., Terai, K., Wise, A. L., Ziazadeh, D. R., Shah, K. J., Gartrell, R. D., Ricke, B. J., Kimura, K. S., Mathur, S., et al. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2236-4 · Cited by 16
The small G-protein RalA promotes progression and metastasis of triple-negative breast cancer
Thies, K., Cole, M. W., Schafer, R., Spehar, J. M., Richardson, D. S., Steck, S., Das, M., Lian, A. W., Ray, A., Shakya, R., et al. (2021) · Breast Cancer Research · doi:10.1186/s13058-021-01438-3 · Cited by 19
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer
Nguyen, T. T., Silva, F. N., & Golemis, E. A. (2022) · The Cancer Journal · doi:10.1097/ppo.0000000000000614 · Cited by 15
Network analysis revealed aurora kinase dysregulation in five gynecological types of cancer
Suman, S., & Mishra, A. (2017) · Oncology Letters · doi:10.3892/ol.2017.7368 · Cited by 18
RalA GTPase and MAP4K4 Function through NDR1 Activation in Stress Response and Apoptotic Signaling
Curie, I., Camonis, J., & Hergovich, A. (2014) · Cell Biology & Cell Metabolism · doi:10.24966/cbcm-1943/100001 · Cited by 15
Pollock, S. R., Schinlever, A. R., Rohani, A., Kashatus, J. A., & Kashatus, D. F. (2019) · PLOS ONE · doi:10.1371/journal.pone.0214764 · Cited by 13
Self-citationDual effects of Ral-activated pathways on p27 localization and TGF-β signaling
Tazat, K., Harsat, M., Goldshmid-Shagal, A., Ehrlich, M., & Henis, Y. I. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e13-01-0007 · Cited by 15
Breaking up is hard to do: RalA, mitochondrial fission and cancer
Kashatus, D. F., & Counter, C. M. (2011) · Small GTPases · doi:10.4161/sgtp.18284 · Cited by 12
Self-citationRas effector switching as a developmental strategy
Reiner, D. J. (2011) · Small GTPases · doi:10.4161/sgtp.2.2.15775 · Cited by 12
Rajasekar, K. V., Campbell, L. J., Nietlispach, D., Owen, D., & Mott, H. R. (2013) · Structure · doi:10.1016/j.str.2013.09.007 · Cited by 11
Crosstalk and Integration of Membrane Trafficking Pathways
Weigert, R. (2012) · InTech eBooks · doi:10.5772/1233 · Cited by 11
RLIP76 (RalBP1): The first piece of the structural puzzle
Mott, H. R., & Owen, D. (2010) · Small GTPases · doi:10.4161/sgtp.1.3.14233 · Cited by 12
RLIP76: A Structural and Functional Triumvirate
Cornish, J., Owen, D., & Mott, H. R. (2021) · Cancers · doi:10.3390/cancers13092206 · Cited by 8
Chamberlain, S. G., Gohlke, A., Shafiq, A., Squires, I. J., Owen, D., & Mott, H. R. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2104219118 · Cited by 8
Differential Response and Resistance to KRAS-Targeted Therapy
Liu, Z., Lenz, H., Yu, J., & Zhang, L. (2025) · Molecular Carcinogenesis · doi:10.1002/mc.23908 · Cited by 7
Aurora kinase: An emerging potential target in therapeutics
Varshney, N., Rani, A., Kashyap, D., Tiwari, D., & Jha, H. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91287-7.00028-4 · Cited by 8
Prenylation and Phosphorylation of Ras Superfamily Small GTPases
Hodges, H. B., Parker, L. E., & Cox, A. D. (2011) · The Enzymes · doi:10.1016/b978-0-12-415922-8.00003-3 · Cited by 8
Self-citationRas Family of Small GTPases in CRC: New Perspectives for Overcoming Drug Resistance
Río-Vilariño, A., del Puerto‐Nevado, L., García‐Foncillas, J., & Cebrián, A. (2021) · Cancers · doi:10.3390/cancers13153757 · Cited by 6
The role of ral signaling and post translational modifications (PTMs) of Ras in cancer
Zinatizadeh, M. R., Zarandi, P. K., Keshavarz‐Fathi, M., Yousefi, M. H., & Rezaei, N. (2022) · Genome Instability & Disease · doi:10.1007/s42764-022-00059-0 · Cited by 6
Posttranslational Modifications of Small G Proteins
Zhou, B., & Cox, A. D. (2014) · Springer eBooks · doi:10.1007/978-3-7091-1806-1_5 · Cited by 6
Self-citationHutchins, C. M., & Gorfe, A. A. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2024.102869 · Cited by 5
Sun, M., Hu, L., Zhao, C.-Y., Lu, X., Ren, Y., Wang, J., Cui, X., & Sun, S. (2021) · Cell Division · doi:10.1186/s13008-021-00071-y · Cited by 6
Rlip76 in ageing and Alzheimer’s disease: Focus on oxidative stress and mitochondrial mechanisms
Bandaru, M., Sultana, O. F., Islam, M. A., Alvir, R. V., & Reddy, P. H. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102600 · Cited by 4
Molecular Machinery Regulating Exocytosis
Shandala, T., Kakavanos-Plew, R., Ng, Y., Bader, C. A., Sorvina, A., Parkinson-Lawrence, E. J., Brooks, R. D., Borlace, G. N., Prodoehl, M. J., & Brooks, D. A. (2012) · InTech eBooks · doi:10.5772/39110 · Cited by 4
Yan, C., Jones, D. N. M., & Theodorescu, D. (2015) · Small GTPases · doi:10.1080/21541248.2015.1018403 · Cited by 5
Making Every Penny Count: Kinase Signaling Transduction, Copper Homeostasis, & Nutrient Sensing
Brady, D. C. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169089 · Cited by 3
Self-citation
Metadata
- Authors
- Lim, K.-H., Brady, D. C., Kashatus, D. F., Ancrile, B. B., Der, C. J., Cox, A. D., & Counter, C. M.
- Affiliations
- Duke University (US)
- Departments of Pharmacology
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Cox, Adrienne D.
- Counter, Christopher M.
- ORCID
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2010-01-01
- Volume
- 30
- Issue
- 2
- Pages
- 508-523
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2798468
- OpenAlex
- W2100469448
- Cited by
- 126
- References
- 69
- Citations by year
- 2026: 1 · 2025: 6 · 2024: 4 · 2023: 2 · 2022: 7 · 2021: 9 · 2020: 6 · 2019: 3 · 2018: 7 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 14
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- U.S. Department of Defense
- National Institutes of Health (5r01ca042978-30, NIH T32, CA67771, CA42978)
- National Cancer Institute (CA42978, R01CA109550, CA94184, CA 109550, CA 67771, R01-CA042978, R21CA126903, U19CA067771, CA126903, R01CA094184)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- AURKA, RalA, RALBP1, oncogenic Ras, small GTPase activation, cell transformation, carcinogenesis, mitosis, signal transduction, protein localization
- MeSH terms
- Animals, Humans, Mutation, Mice, SCID, Protein Serine-Threonine Kinases, ATP-Binding Cassette Transporters, ras Proteins, GTPase-Activating Proteins, ral GTP-Binding Proteins, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Aurora Kinase A, Aurora Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.